Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8947 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8767 |
High Similarity |
NPD4628 |
Phase 3 |
0.8627 |
High Similarity |
NPD1934 |
Approved |
0.8581 |
High Similarity |
NPD3882 |
Suspended |
0.8581 |
High Similarity |
NPD6190 |
Approved |
0.8571 |
High Similarity |
NPD2801 |
Approved |
0.8562 |
High Similarity |
NPD3818 |
Discontinued |
0.8516 |
High Similarity |
NPD3817 |
Phase 2 |
0.8472 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.8452 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8438 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8438 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8438 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8415 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8405 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8395 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8354 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.8344 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8344 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8333 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.831 |
Intermediate Similarity |
NPD9494 |
Approved |
0.8282 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8224 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8224 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.8182 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8176 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8133 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8117 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8105 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8095 |
Intermediate Similarity |
NPD447 |
Suspended |
0.8089 |
Intermediate Similarity |
NPD6385 |
Approved |
0.8089 |
Intermediate Similarity |
NPD6386 |
Approved |
0.8086 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8084 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8079 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8069 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8067 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.8065 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.8063 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.805 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8038 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8028 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.8025 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7987 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7941 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7939 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7901 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7898 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7891 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7881 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7875 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7857 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7853 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7838 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7834 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7832 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7812 |
Intermediate Similarity |
NPD37 |
Approved |
0.7811 |
Intermediate Similarity |
NPD7038 |
Approved |
0.7811 |
Intermediate Similarity |
NPD7039 |
Approved |
0.7805 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7803 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7799 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7785 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7785 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7778 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7778 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD4965 |
Approved |
0.775 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7736 |
Intermediate Similarity |
NPD3455 |
Phase 2 |
0.7716 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7712 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7712 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7711 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7708 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7707 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7707 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7706 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7697 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7679 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7677 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7677 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7677 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7662 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7647 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7647 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7635 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7633 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7625 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7622 |
Intermediate Similarity |
NPD17 |
Approved |
0.7616 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7616 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7605 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7595 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7582 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7582 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7582 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7576 |
Intermediate Similarity |
NPD919 |
Approved |
0.7551 |
Intermediate Similarity |
NPD1203 |
Approved |
0.755 |
Intermediate Similarity |
NPD1240 |
Approved |
0.755 |
Intermediate Similarity |
NPD943 |
Approved |
0.7547 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7535 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7533 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7517 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7516 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7514 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7514 |
Intermediate Similarity |
NPD8312 |
Approved |
0.75 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD3688 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7484 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7484 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7484 |
Intermediate Similarity |
NPD3146 |
Approved |
0.7466 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7456 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7455 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7452 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7451 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7451 |
Intermediate Similarity |
NPD6653 |
Approved |
0.745 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7439 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7434 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7431 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7417 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7416 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7397 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7381 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7381 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7372 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7372 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7368 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7361 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7358 |
Intermediate Similarity |
NPD7440 |
Discontinued |
0.7357 |
Intermediate Similarity |
NPD228 |
Approved |
0.7355 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7355 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7351 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7347 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7346 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7346 |
Intermediate Similarity |
NPD3686 |
Approved |
0.7342 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7341 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD1006 |
Clinical (unspecified phase) |
0.7315 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7308 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7305 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7303 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7301 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7284 |
Intermediate Similarity |
NPD920 |
Approved |
0.7273 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD5647 |
Approved |
0.7267 |
Intermediate Similarity |
NPD2163 |
Approved |
0.7261 |
Intermediate Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.7261 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7261 |
Intermediate Similarity |
NPD2353 |
Approved |
0.726 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7254 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7248 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7235 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7233 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.723 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7225 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7215 |
Intermediate Similarity |
NPD4534 |
Discontinued |
0.7211 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7208 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7207 |
Intermediate Similarity |
NPD6377 |
Clinical (unspecified phase) |
0.7205 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7197 |
Intermediate Similarity |
NPD6032 |
Approved |
0.7195 |
Intermediate Similarity |
NPD824 |
Approved |
0.7192 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7191 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.719 |
Intermediate Similarity |
NPD411 |
Approved |
0.7188 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7179 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.717 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7162 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.716 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7152 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7152 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7134 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7133 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7117 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7108 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD6873 |
Phase 2 |
0.7107 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7107
|
Intermediate Similarity |
NPD5958 |
Discontinued |